PDL BioPharma (PDLI) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Net income per diluted share (in dollars per share): 0.08
Today's EPS Names:
MFON, SICP, LBAS, More
Financial Fact:
Net income per diluted share (in dollars per share): 0.08
Today's EPS Names:
MFON, SICP, LBAS, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q3 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $53.6 million versus the consensus estimate of $50.69 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bank of America (BAC) Tops Q1 EPS by $0.07, Beats on Revenue
- Bank of America meets earnings estimates, beats revenue expectations in Q1 2024
- UnitedHealth Group (UNH) Tops Q1 EPS by 29c, Tops on Revenue; Offers FY24 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
